Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing state-level sites (Arizona, Arkansas, California, Colorado, Illinois, Kansas, Kentucky, Minnesota, Nebraska, New York, Ohio, Oregon, Texas, Virginia, Washington) and updated metadata to Last Update Posted (Estimated) and Revision: v3.3.3. The old per-state location headers and prior revision indicator were removed.
    Difference
    1%
    Check dated 2025-12-23T12:42:07.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    New study sites were added in Texas and Virginia, including Texas Oncology - Central South (Balcones Dr) and James Casey, South Hill VA, VCU Health Community Memorial Hospital, and Oncology & Hematology Associates of Southwest Virginia, Inc. Some sites in Virginia Beach, Newport News, and Williamsburg were removed, and the reported total number of locations updated from 92 to 88.
    Difference
    0.7%
    Check dated 2025-12-16T03:20:13.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:03:20.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Updated the study record with the current official title for NCT04609566 (A Phase 2 Study of Brentuximab Vedotin in Combination With Pembrolizumab in Participants With Metastatic Solid Malignancies) and the enrollment figure (161) along with the Last Update Posted (Estimated) date; removed the prior funding-notice from the page.
    Difference
    0.5%
    Check dated 2025-11-17T15:06:02.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    No significant changes detected in core study content; observed differences are superficial formatting or layout adjustments rather than edits to eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:32:01.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a new software version (v3.2.0); removed the older v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T13:24:33.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.